LA BioMed Launches Groundbreaking Study on Deadly Skin Infections

$5.3 million NIH grant will fund research on effective therapies for antibiotic-resistant strains

LA BioMed Leads Groundbreaking Studies on Deadly Infectious Disease

Two studies are part of broader effort to take aim at one of the world’s deadliest infections